Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seagen Inc.
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
ViroMissile, Inc.
Erasca, Inc.
Pfizer
Tizona Therapeutics, Inc
Genentech, Inc.
St. Jude Children's Research Hospital
MacroGenics
City of Hope Medical Center
Conjupro Biotherapeutics, Inc.
Pfizer
AgonOx, Inc.
Innate Pharma
Novartis
City of Hope Medical Center
Amgen
University Health Network, Toronto
NeoTX Therapeutics Ltd.
AccSalus Biosciences, Inc.
Abramson Cancer Center at Penn Medicine
West China Hospital
HiFiBiO Therapeutics
HiFiBiO Therapeutics
Seattle Children's Hospital
Bolt Biotherapeutics, Inc.
AstraZeneca
Tesaro, Inc.
St. Jude Children's Research Hospital
HiFiBiO Therapeutics
Actym Therapeutics, Inc.
MacroGenics
Sichuan Baili Pharmaceutical Co., Ltd.
Ikena Oncology
Pfizer
UNC Lineberger Comprehensive Cancer Center
Valo Therapeutics Oy
Memgen, Inc.
Novartis
Pfizer
Arcus Biosciences, Inc.
Hoffmann-La Roche
Day One Biopharmaceuticals, Inc.
Toray Industries, Inc
University of Virginia
Genentech, Inc.
Eli Lilly and Company